Polyrizon Ltd. (PLRZ) — SEC Filings
Polyrizon Ltd. (PLRZ) — 50 SEC filings. Latest: EFFECT (May 5, 2026). Includes 45 6-K, 2 20-F, 1 EFFECT.
View Polyrizon Ltd. on SEC EDGAR
Overview
Polyrizon Ltd. (PLRZ) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 424B5 filed on Apr 8, 2026: Polyrizon Ltd. filed a prospectus supplement (424B5) on April 8, 2026, related to its securities. The filing, with SEC Accession No. 0001213900-26-041507, provides updated information for investors. The company is located in Ra'anana, Israel.
Sentiment Summary
Across 50 filings, the sentiment breakdown is: 10 bullish, 2 bearish, 36 neutral, 2 mixed. The dominant filing sentiment for Polyrizon Ltd. is neutral.
Filing Type Overview
Polyrizon Ltd. (PLRZ) has filed 1 EFFECT, 45 6-K, 1 424B5, 1 20-F/A, 2 20-F with the SEC between Oct 2024 to May 2026.
Filings by Year
Recent SEC Filings (50)
Risk Profile
Risk Assessment: Of PLRZ's 45 recent filings, 2 were flagged as high-risk, 28 as medium-risk, and 15 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Key Executives
- Tomer Izraeli
- Yehonatan Zalman Vinokur
- Assaf Itzhaik
- Liat Sidi
- Omer Srugo
- Liron Carmel
- Dr. Michal Meir
Industry Context
Polyrizon Ltd. operates within a sector that requires robust financial reporting and internal controls, especially given its status as a foreign private issuer. The company's adherence to frameworks like COSO and compliance with SEC regulations are critical for maintaining investor confidence and market access.
Top Tags
press-release (8) · medical-devices (7) · drug-development (5) · shareholder-meeting (4) · corporate-governance (4) · clinical-trial (4) · drug-delivery (4) · regulatory-filing (3) · manufacturing (3) · compliance (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Document Size (bytes) | 528829 | Size of the prospectus supplement file (ea0285368-424b5_polyrizon.htm) |
| Total fees paid to auditor in 2025 | $170,154 | Increased from $135,000 in 2024, reflecting audit, audit-related, and tax services. |
| Audit fees paid in 2025 | $100,000 | Consistent with audit fees paid in 2024, indicating stable core audit costs. |
| Ordinary Shares outstanding | 1,608,266 | As of December 31, 2025, representing the total number of shares. |
| Fiscal year ended | 2025 | The period covered by the amended annual report. |
| Filing date of 20-F/A | 2026-03-27 | Date the amendment was filed, correcting the original March 25, 2026 filing. |
| May Reverse Share Split Ratio | 1-for-250 | Effected on May 27, 2025, to consolidate ordinary shares and maintain Nasdaq listing. |
| November Reverse Share Split Ratio | 1-for-6 | Effected on November 28, 2025, further consolidating ordinary shares and maintaining Nasdaq listing. |
| Ordinary Shares Outstanding | 1,608,266 | As of December 31, 2025, after giving effect to both reverse splits. |
| Revenue from Product Candidate Sales | $0 | Polyrizon has never generated any revenue from product candidate sales since its inception. |
| Offering Proceeds | $5.0M | Calculated from 552,269 shares at $9.00 per share, representing capital raised. |
| Share Price | $9.00 | The price at which ordinary shares were sold in the registered direct offering. |
| Commission file number | 001-42375 | Identifies the company's SEC filings |
| SEC File Number | 001-42375 | Identifies Polyrizon Ltd.'s filings with the SEC. |
| Reverse Split Ratio | 1-for-250 | Indicates a significant consolidation of shares. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Polyrizon Ltd. (PLRZ)?
Polyrizon Ltd. has 50 recent SEC filings from Oct 2024 to May 2026, including 45 6-K, 2 20-F, 1 EFFECT. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of PLRZ filings?
Across 50 filings, the sentiment breakdown is: 10 bullish, 2 bearish, 36 neutral, 2 mixed. The dominant sentiment is neutral.
Where can I find Polyrizon Ltd. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Polyrizon Ltd. (PLRZ) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Polyrizon Ltd.?
Financial highlights for Polyrizon Ltd. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for PLRZ?
The investment thesis for PLRZ includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Polyrizon Ltd.?
Key executives identified across Polyrizon Ltd.'s filings include Tomer Izraeli, Yehonatan Zalman Vinokur, Assaf Itzhaik, Liat Sidi, Omer Srugo and 2 others.
What are the main risk factors for Polyrizon Ltd. stock?
Of PLRZ's 45 assessed filings, 2 were flagged high-risk, 28 medium-risk, and 15 low-risk.
What are recent predictions and forward guidance from Polyrizon Ltd.?
Forward guidance and predictions for Polyrizon Ltd. are extracted from SEC filings as they are enriched.